QurAlis Corporation ("QurAlis"), a clinical-stage biotechnology company driving scientific breakthroughs into powerful precision medicines that have the potential to alter the trajectory of ...
Nuclein, a leader in rapid, point-of-care molecular diagnostics, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance and a Clinical Laboratory Improvement ...
NEW YORK – The Davos Alzheimer's Collaborative (DAC) announced on Wednesday that it is partnering with Janssen Research & Development and Danaher subsidiary Beckman Coulter Diagnostics to validate ...